Baseline susceptibility of primary HIV-2 to entry inhibitors.
Borrego P, Calado R, Marcelino JM, Bártolo I, Rocha C, Cavaco-Silva P, Doroana M, Antunes F, Maltez F, Caixas U, Barroso H, Taveira N.
Borrego P, et al. Among authors: calado r.
Antivir Ther. 2012;17(3):565-70. doi: 10.3851/IMP1996. Epub 2012 Jan 25.
Antivir Ther. 2012.
PMID: 22293827
Free article.